Apogee Therapeutics Inc (NAS:APGE)
$ 134.12 -0.055 (-0.04%) Market Cap: 10.14 Bil Enterprise Value: 9.09 Bil PE Ratio: 0 PB Ratio: 8.00 GF Score: 12/100

Apogee Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 02:10 PM GMT
Release Date Price: $68.5 (-3.41%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

APGE.OQ - Apogee Therapeutics Inc
Apogee Therapeutics Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 02:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everyone. Tyler Van Buren here, senior biotech analyst at TD Cowan.

Thank you very much again for joining TD Cowan's 46th annual healthcare conference. Very excited to be kicking off the company sessions with a fireside chat with APG Therapeutics, best idea for 25. You guys made me look smart last year. I needed it, and hopefully you make me look smart again because it's the best idea two years in a row. A lot of very exciting readouts coming up, but it's my pleasure to introduce Michael Henderson, the CEO, Karl Damkowski, the Chief Medical Officer, Jeff Harkness, the Chief Commercial Officer, and Jane Prurchett Henderson, the Chief Financial Officer. It's a privilege to have you all here with
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot